|
[1] Wu X, Wang S, Chen B, et al. Muscle-derived stem cells: isolation, characterization, differentiation, and application in cell and gene therapy. Cell Tissue Res, 2010, 340(3):549-567.
[2] Vourch P, Romero-Ramos M, Chivatakarn O, et al. Isolation and characterization of cells with neurogenic potential from adult skeletal muscle. Biochem Biophys Res Commun, 2004, 317(3):893-901.
[3] Arsic N, Mamaeva D, Lamb N J, et al. Muscle-derived stem cells isolated as non-adherent population give rise to cardiac, skeletal muscle and neural lineages. Exp Cell Res, 2008, 314(6):1266-1280.
[4] Gharaibeh B, Lu A, Tebbets J, et al. Isolation of a slowly adhering cell fraction containing stem cells from murine skeletal muscle by the preplate technique. Nat Protoc, 2008, 3(9):1501-1509.
[5] Wei Y, Li Y, Chen C, et al. Human skeletal muscle-derived stem cells retain stem cell properties after expansion in myosphere culture. Exp Cell Res, 2011, 317(7):1016-1027.
[6] Sherwood R I, Christensen J L, Conboy I M, et al. Isolation of adult mouse myogenic progenitors: functional heterogeneity of cells within and engrafting skeletal muscle. Cell, 2004, 119(4):543-554.
[7] Bauermeister K T, Stolting S, Kaczmarek P M, et al. Hematopoietic progenitor cells residing in muscle engraft into bone marrow following transplantation. Int J Hematol, 2004, 79(5):488-494.
[8] Tsuboi K, Kawada H, Toh E, et al. Potential and origin of the hematopoietic population in human skeletal muscle. Leuk Res, 2005, 29(3):317-324.
[9] McKinney-Freeman S L, Jackson K A, Camargo F D, et al. Muscle-derived hematopoietic stem cells are hematopoietic in origin. Proc Natl Acad Sci U S A, 2002, 99(3):1341-1346.
[10] Jiang Y, Vaessen B, Lenvik T, et al. Multipotent progenitor cells can be isolated from postnatal murine bone marrow, muscle, and brain. Exp Hematol, 2002, 30(8):896-904.
[11] Jiang Y, Jahagirdar B N, Reinhardt R L, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature, 2002, 418(6893):41-49.
[12] Ji K H, Xiong J, Hu K M, et al. Simultaneous expression of Oct4 and genes of three germ layers in single cell-derived multipotent adult progenitor cells. Ann Hematol, 2008, 87(6):431-438.
[13] Aranguren X L, Luttun A, Clavel C, et al. In vitro and in vivo arterial differentiation of human multipotent adult progenitor cells. Blood, 2007, 109(6):2634-2642.
[14] Zhong J F, Zhan Y, Anderson W F, et al. Murine hematopoietic stem cell distribution and proliferation in ablated and nonablated bone marrow transplantation. Blood, 2002, 100(10):3521-3526.
[15] Negroni E, Riederer I, Chaouch S, et al. In vivo myogenic potential of human CD133(+) muscle-derived stem cells: a quantitative study. Mol Ther, 2009.
[16] Tamaki T, Akatsuka A, Ando K, et al. Identification of myogenic-endothelial progenitor cells in the interstitial spaces of skeletal muscle. J Cell Biol, 2002, 157(4):571-577.
[17] Tamaki T, Uchiyama Y, Okada Y, et al. Functional recovery of damaged skeletal muscle through synchronized vasculogenesis, myogenesis, and neurogenesis by muscle-derived stem cells. Circulation, 2005, 112(18):2857-2866.
[18] Tamaki T, Okada Y, Uchiyama Y, et al. Synchronized reconstitution of muscle fibers, peripheral nerves and blood vessels by murine skeletal muscle-derived CD34(-)/45 (-) cells. Histochem Cell Biol, 2007, 128(4):349-360.
[19] Sacco A, Doyonnas R, Kraft P, et al. Self-renewal and expansion of single transplanted muscle stem cells. Nature, 2008, 456(7221):502-506.
[20] Seaberg R M, Smukler S R, Kieffer T J, et al. Clonal identification of multipotent precursors from adult mouse pancreas that generate neural and pancreatic lineages. Nat Biotechnol, 2004, 22(9):1115-1124.
[21] Tamaki T, Okada Y, Uchiyama Y, et al. Clonal multipotency of skeletal muscle-derived stem cells between mesodermal and ectodermal lineage. Stem Cells, 2007, 25(9):2283-2290.
[22] Tamaki T, Okada Y, Uchiyama Y, et al. Skeletal muscle-derived CD34+/45-and CD34-/45-stem cells are situated hierarchically upstream of Pax7+ cells. Stem Cells Dev, 2008, 17(4):653-667.
[23] Tamaki T, Akatsuka A, Okada Y, et al. Cardiomyocyte formation by skeletal muscle-derived multi-myogenic stem cells after transplantation into infarcted myocardium. PLoS One, 2008, 3(3):e1789.
[24] Tamaki T, Uchiyama Y, Okada Y, et al. Clonal Differentiation of Skeletal Muscle-Derived CD34-/45-Stem Cells into Cardiomyocytes in vivo. Stem Cells Dev, 2009.
[25] Zheng B, Cao B, Crisan M, et al. Prospective identification of myogenic endothelial cells in human skeletal muscle. Nat Biotechnol, 2007, 25(9):1025-1034.
[26] Gerald A. The heterogeneity of clonally derived purified murine marrow stem cell colonies. Blood, 2005.
[27] Wright V, Peng H, Usas A, et al. BMP4-expressing muscle-derived stem cells differentiate into osteogenic lineage and improve bone healing in immunocompetent mice. Mol Ther, 2002, 6(2):169-178.
[28] Usas A, Ho A M, Cooper G M, et al. Bone regeneration mediated by BMP4-expressing muscle-derived stem cells is affected by delivery system. Tissue Eng Part A, 2009, 15(2):285-293.
[29] Shen H C, Peng H, Usas A, et al. Ex vivo gene therapy-induced endochondral bone formation: comparison of muscle-derived stem cells and different subpopulations of primary muscle-derived cells. Bone, 2004, 34(6):982-992.
[30] Adachi N, Sato K, Usas A, et al. Muscle derived, cell based ex vivo gene therapy for treatment of full thickness articular cartilage defects. J Rheumatol, 2002, 29(9):1920-1930.
[31] Goldring M B. Are bone morphogenetic proteins effective inducers of cartilage repair? Ex vivo transduction of muscle-derived stem cells. Arthritis Rheum, 2006, 54(2):387-389.
[32] Payne T R, Oshima H, Sakai T, et al. Regeneration of dystrophin-expressing myocytes in the mdx heart by skeletal muscle stem cells. Gene Ther, 2005, 12(16):1264-1274.
[33] Ikezawa M, Cao B, Qu Z, et al. Dystrophin delivery in dystrophin-deficient DMDmdx skeletal muscle by isogenic muscle-derived stem cell transplantation. Hum Gene Ther, 2003, 14(16):1535-1546.
[34] Baek Y S, Kang S H, Park J S, et al. Long-term cultured skeletal muscle-derived neural precursor cells and their neurogenic potentials. Neuroreport, 2009, 20(12):1109-1114.
[35] Schultz S S, Lucas P A. Human stem cells isolated from adult skeletal muscle differentiate into neural phenotypes. J Neurosci Methods, 2006, 152(1-2):144-155.
[36] Allan D S, Jay K E, Bhatia M. Hematopoietic capacity of adult human skeletal muscle is negligible. Bone Marrow Transplant, 2005, 35(7):663-666.
[37] Farace F, Prestoz L, Badaoui S, et al. Evaluation of hematopoietic potential generated by transplantation of muscle-derived stem cells in mice. Stem Cells Dev, 2004, 13(1):83-92.
[38] Bueno D F, Kerkis I, Costa A M, et al. New source of muscle-derived stem cells with potential for alveolar bone reconstruction in cleft lip and/or palate patients. Tissue Eng Part A, 2009, 15(2):427-435.
[39] Kim K S, Lee J H, Ahn H H, et al. The osteogenic differentiation of rat muscle-derived stem cells in vivo within in situ-forming chitosan scaffolds. Biomaterials, 2008, 29(33):4420-4428.
[40] Corsi K A, Pollett J B, Phillippi J A, et al. Osteogenic potential of postnatal skeletal muscle-derived stem cells is influenced by donor sex. J Bone Miner Res, 2007, 22(10):1592-1602.
[41] Kubo S, Cooper G M, Matsumoto T, et al. Blocking vascular endothelial growth factor with soluble Flt-1 improves the chondrogenic potential of mouse skeletal muscle-derived stem cells. Arthritis Rheum, 2009, 60(1):155-165.
[42] Matsumoto T, Cooper G M, Gharaibeh B, et al. Cartilage repair in a rat model of osteoarthritis through intraarticular transplantation of muscle-derived stem cells expressing bone morphogenetic protein 4 and soluble Flt-1. Arthritis Rheum, 2009, 60(5):1390-1405.
[43] Claros S, Alonso M, Becerra J, et al. Selection and induction of rat skeletal muscle-derived cells to the chondro-osteogenic lineage. Cell Mol Biol (Noisy-le-grand), 2008, 54(1):1-10.
[44] Kondo T, Case J, Srour E F, et al. Skeletal muscle-derived progenitor cells exhibit neural competence. Neuroreport, 2006, 17(1):1-4.
[45] Arriero M, Brodsky S V, Gealekman O, et al. Adult skeletal muscle stem cells differentiate into endothelial lineage and ameliorate renal dysfunction after acute ischemia. Am J Physiol Renal Physiol, 2004, 287(4):F621-627.
[46] Nieponice A, Soletti L, Guan J, et al. Development of a tissue-engineered vascular graft combining a biodegradable scaffold, muscle-derived stem cells and a rotational vacuum seeding technique. Biomaterials, 2008, 29(7):825-833.
[47] Zhou C, Zhang C. Cell therapy for Duchenne muscular dystrophy. Zhonghua Yi Xue Yi Chuan Xue Za Zhi, 2006, 23(6):659-661.
[48] Chaouch S, Mouly V, Goyenvalle A, et al. Immortalized skin fibroblasts expressing conditional MyoD as a renewable and reliable source of converted human muscle cells to assess therapeutic strategies for muscular dystrophies: validation of an exon-skipping approach to restore dystrophin in duchenne muscular dystrophy cells. Hum Gene Ther, 2009, 20(7):784-790.
[49] Smaldone M C, Chancellor M B. Muscle derived stem cell therapy for stress urinary incontinence. World J Urol, 2008, 26(4):327-332.
[50] Kwon D, Kim Y, Pruchnic R, et al. Periurethral cellular injection: comparison of muscle-derived progenitor cells and fibroblasts with regard to efficacy and tissue contractility in an animal model of stress urinary incontinence. Urology, 2006, 68(2):449-454.
[51] Furuta A, Jankowski R J, Pruchnic R, et al. The potential of muscle-derived stem cells for stress urinary incontinence. Expert Opin Biol Ther, 2007, 7(10):1483-1486.
[52] Smaldone M C, Chen M L, Chancellor M B. Stem cell therapy for urethral sphincter regeneration. Minerva Urol Nefrol, 2009, 61(1):27-40.
|
